# Robert J. Heine

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robert-j-heine/

## Facts

| Field | Value |
| --- | --- |
| Citations | 44,325 |
| Field | Diabetes, Cardiovascular Risks, and Lipoproteins |
| h-index | 103 |
| i10-index | 301 |
| Last Known Institution | Eli Lilly (United States) |
| OpenAlex ID | https://openalex.org/A5113467761 |
| Works | 437 |

## Researcher papers

- [Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial](https://scholariq.org/papers/secondary-prevention-of-macrovascular-events-in-patients-with-type-2-diabetes-in/)
- [Translating the A1C Assay Into Estimated Average Glucose Values](https://scholariq.org/papers/translating-the-a1c-assay-into-estimated-average-glucose-values/)
- [Impaired Fasting Glucose and Impaired Glucose Tolerance](https://scholariq.org/papers/impaired-fasting-glucose-and-impaired-glucose-tolerance/)
- [Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria](https://scholariq.org/papers/glucose-tolerance-and-mortality-comparison-of-who-and-american-diabetes/)
- [Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy](https://scholariq.org/papers/management-of-hyperglycemia-in-type-2-diabetes-a-consensus-algorithm-for-the/)
- [Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis](https://scholariq.org/papers/depression-as-a-risk-factor-for-the-onset-of-type-2-diabetes-mellitus-a-meta/)
- [Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study](https://scholariq.org/papers/survival-as-a-function-of-hba1c-in-people-with-type-2-diabetes-a-retrospective/)
- [Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes](https://scholariq.org/papers/exenatide-versus-insulin-glargine-in-patients-with-suboptimally-controlled-type/)
- [Moderate Alcohol Consumption Lowers the Risk of Type 2 Diabetes](https://scholariq.org/papers/moderate-alcohol-consumption-lowers-the-risk-of-type-2-diabetes/)
- [Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial](https://scholariq.org/papers/tirzepatide-versus-insulin-glargine-in-type-2-diabetes-and-increased/)
- [One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients](https://scholariq.org/papers/one-year-treatment-with-exenatide-improves-cell-function-compared-with-insulin/)
- [Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer’s disease](https://scholariq.org/papers/effect-of-diabetes-on-caregiver-burden-in-an-observational-study-of-individuals/)

## Researcher topics

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Education](https://scholariq.org/topics/diabetes-management-and-education/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

## Researcher university

- [Eli Lilly (United States)](https://scholariq.org/institutions/eli-lilly-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.